Finally, the first and the largest #metaanalysis on the upfront combination lipid lowering therapy (#LLT) of moderate to high intensity #statin therapy and #ezetimibe vs statin monotherapy has been released in the Mayo Clinic Proceedings by Elsevier. Based on the data from 14 studies with 108,373 very high-risk #patients we showed that #combination LLT:👉 significantly […]

The European Program for Prevention (www.epprevention.eu), which we officially launched on June 4 in Warsaw, has been published in the Global Heart, the official journal of the World Heart Federation. The EPP offers clear, practical prevention solutions from Central and Eastern Europe (CEE) that can be readily adopted elsewhere. It is a tool that can […]

Another important International Lipid Expert Panel (ILEP) #metaanalysis on #therapy for homozygous familial #hypercholesterolemia (#HoFH) has just been published in #Drugs (IF = 14.4) by Springer Nature. Excellent work by Prof. Ibadete Bytyçi — ILEP’s Statistical Lead — and the Kosovo team! This is crucial because HoFH remains severely underdiagnosed and is often identified too […]

#IschemicStroke is a significant global health challenge, accounting for approximately 66% of all strokes worldwide ‼️ Recent data indicates that stroke was 👉 the third leading cause of death (10.7 % of all deaths), following ischemic heart disease #IHD and #COVID19. In 2021, nearly 94 million people were living with the consequences of a stroke, and […]